(Q37119281)

18 August 2017

1 reference

title

Endocannabinoid system overactivity and the metabolic syndrome: prospects for treatment (English)

1 reference

18 August 2017

main subject

endocannabinoid system

0 references

1 reference

Jennifer M Perkins

1

1 reference

18 August 2017

Stephen N Davis

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

18 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Current diabetes report

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

12-19

1 reference

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0004-3

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

1 reference

12 December 2020

Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain

1 reference

12 December 2020

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

12 December 2020

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

12 December 2020

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

12 December 2020

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

1 reference

12 December 2020

The cannabinoid receptors.

1 reference

12 December 2020

Endocannabinoids and the control of energy balance

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Association between adiponectin and mediators of inflammation in obese women.

1 reference

12 December 2020

Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

1 reference

12 December 2020

Endocannabinoid control of food intake and energy balance

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

The effects of cannabinoids on the brain

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

12 December 2020

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

12 December 2020

The gastrointestinal pharmacology of cannabinoids: an update.

1 reference

12 December 2020

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

1 reference

12 December 2020

Activation of the peripheral endocannabinoid system in human obesity

1 reference

12 December 2020

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

12 December 2020

Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis

1 reference

12 December 2020

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

12 December 2020

Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S11892-008-0004-3

Identifiers

DOI

1 reference

18 August 2017

1 reference